TALK SLIDES FOUND HERE
The Department of Statistics and Biostatistics at Rutgers
University, and its Biostatistics Institute, are hosting the 2008
Rutgers Biostatistics Day on Friday, April 25, 2008.
One of the main objectives of the Biostatistics Institute is to
foster collaborative research on Biopharmaceutical Statistics.
The Rutgers Biostatistics Days are periodic events designed to
provide opportunities for interactions between statisticians from
both industry and academia. We invite you to join us on April 25,
and find out more about the new initiatives of the Rutgers Biostatistics
Institute.
Program
9:00AM-9:15AM: Registration.
9:15AM-9:20AM: Opening remarks.
Regina Liu, Chair, Dept of Statistics and Biostatistics, Rutgers Univeristy
9:20AM-10:10AM: Key Note Speaker.
Chair:
James Colaianne, Johnson & Johnson.
William DuMouchel, Lincoln Technologies.
"Data Mining for Drug-Adverse Event Associations."
10:30AM-11:30PM: Session I: Data mining applications to Safety
Chair:
Hui Quan, Sanofi-Aventis.
Jose Alvir, Ha Nguyen, Frank Caridi, Pfizer Inc. J. Cabrera, Rutgers.
"A new data mining paradigm for Biopharmaceutical data"
Nandini Raghavan, Johnson & Johnson.
"Developing Genomic Biomarkers for Early Drug Safety Screens".
11:30PM-1:00PM: Lunch Break
1:00PM-2:30PM: Session II: Biomarkers Validation, Translational Medicine
Chair: Edith Zang, Eisai Inc.
Michael Ochs, Johns Hopkins University.
"Measuring Signaling Activity in Cancer Cells from Microarray Data"
Rebecka Jornsten, Rutgers University.
"Simultaneous Model Selection via Rate-Distortion Theory, with Applications
to Clustering and Significance Analysis of Gene Expression Data"
Peggy H. Wong, Merck Research Laboratories
"Statistical challenges in Utilizing Gene Expression and Genetics in Biomarker Research".
2:50PM-4:20PM: Session III: Interim Analysis, Adaptive designs.
Chair:
Jose Pinheiro, Novartis Inc.
Jeff Maca, Novartis Inc.
Zhenming Shun, Sanofi-Adventis Inc.
"Interim treatment selection using normal approximation in clinical trials".
Keaven Anderson, Merck Inc, Qin Liu,Johnson & Johnson PRD
"On Adaptive Extensions of Group Sequential
Trials"
4:20PM-5:00PM: Reception.
The wine and cheese reception will
provide a great opportunity for further interaction.
Additional Information
1. Registration.
There is no registration fee. To facilitate planning for this event
participants are required to register on line by April 20.
2. Driving directions and parking
3. Organizing committee
Rutgers members:
Javier Cabrera (chair),
Email: cabrera@stat.rutgers.edu
John Kolassa,
Email: kolassa@stat.rutgers.edu
Regina Liu,
Email: rliu@stat.rutgers.edu
Bill Strawderman,
Email: straw@stat.rutgers.edu
Industry members:
Caridi, Frank, Pfizer Inc.
Email: Frank.Caridi@pfizer.com
James Colaianne, JnJ PRD
Email: JColaian@PRDUS.JNJ.COM
Vladimir Dragalin, Wyeth Inc.
Email: dragalv@wyeth.com
Mani Lakshminarayanan, Merck Inc.
Email: mani_lakshminarayanan@merck.com
Jose Pinheiro, Novartis Inc.
Email: jose.pinheiro@novartis.com
Hui Quan, Sanofi-Aventis Inc.
Email: Hui.Quan@sanofi-aventis.com
Edith Zang, Eisai Inc.
Email: Edith_Zang@Eisai.com
4. Conference coordinator.
Marcy Collins.
Email: collins@stat.rutgers.edu
